These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 18660719

  • 21. Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
    Hawkins R, Grunberg S.
    Clin J Oncol Nurs; 2009 Feb; 13(1):54-64. PubMed ID: 19193549
    [Abstract] [Full Text] [Related]

  • 22. Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
    Gore L, Chawla S, Petrilli A, Hemenway M, Schissel D, Chua V, Carides AD, Taylor A, Devandry S, Valentine J, Evans JK, Oxenius B, Adolescent Aprepitant in Cancer Study Group.
    Pediatr Blood Cancer; 2009 Feb; 52(2):242-7. PubMed ID: 18985740
    [Abstract] [Full Text] [Related]

  • 23. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V, Wan HS, Chan A.
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [Abstract] [Full Text] [Related]

  • 24. Aprepitant (emend) for prevention of nausea and vomiting due to cancer chemotherapy.
    Med Lett Drugs Ther; 2003 Aug 04; 45(1162):62-3. PubMed ID: 12888739
    [No Abstract] [Full Text] [Related]

  • 25. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J.
    Nat Clin Pract Oncol; 2008 Jan 04; 5(1):32-43. PubMed ID: 18097455
    [Abstract] [Full Text] [Related]

  • 26. Regimen-related gastrointestinal toxicities in cancer patients.
    Sonis ST.
    Curr Opin Support Palliat Care; 2010 Mar 04; 4(1):26-30. PubMed ID: 20040879
    [Abstract] [Full Text] [Related]

  • 27. Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.
    Massa E, Astara G, Madeddu C, Dessì M, Loi C, Lepori S, Mantovani G.
    Crit Rev Oncol Hematol; 2009 Apr 04; 70(1):83-91. PubMed ID: 18723369
    [Abstract] [Full Text] [Related]

  • 28. Updated clinical practice guidelines for the prevention and treatment of mucositis.
    Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology.
    Cancer; 2007 Mar 01; 109(5):820-31. PubMed ID: 17236223
    [Abstract] [Full Text] [Related]

  • 29. Casopitant: a new warrior in the antiemetic crusade.
    Khojasteh A, Khojasteh A, Thornburg BG, Maher KR.
    Expert Opin Pharmacother; 2009 Jun 01; 10(8):1367-76. PubMed ID: 19445564
    [Abstract] [Full Text] [Related]

  • 30. [Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool].
    Yamaguchi M, Ogawa T, Watanabe M, Anami S, Kamigaki S, Nishikawa N, Ono T, Furukawa H.
    Gan To Kagaku Ryoho; 2009 Oct 01; 36(10):1691-6. PubMed ID: 19838029
    [Abstract] [Full Text] [Related]

  • 31. The difficult trials.
    Herrstedt J.
    Onkologie; 2009 Feb 01; 32(1-2):7-8. PubMed ID: 19209012
    [No Abstract] [Full Text] [Related]

  • 32. WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms.
    Kearney N, Miller M, Maguire R, Dolan S, MacDonald R, McLeod J, Maher L, Sinclair L, Norrie J, Wengström Y.
    Eur J Oncol Nurs; 2008 Dec 01; 12(5):443-8. PubMed ID: 18842457
    [Abstract] [Full Text] [Related]

  • 33. Intestinal mucositis: mechanisms and management.
    Keefe DM.
    Curr Opin Oncol; 2007 Jul 01; 19(4):323-7. PubMed ID: 17545794
    [Abstract] [Full Text] [Related]

  • 34. [Nausea and vomiting in cancer patients].
    Lévy E, Scotté F, Médioni J, Oudard S.
    Rev Prat; 2006 Nov 30; 56(18):2015-9. PubMed ID: 17274504
    [Abstract] [Full Text] [Related]

  • 35. Review of acupressure studies for chemotherapy-induced nausea and vomiting control.
    Lee J, Dodd M, Dibble S, Abrams D.
    J Pain Symptom Manage; 2008 Nov 30; 36(5):529-44. PubMed ID: 18440769
    [Abstract] [Full Text] [Related]

  • 36. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.
    Lajolo PP, de Camargo B, del Giglio A.
    Am J Clin Oncol; 2009 Feb 30; 32(1):23-6. PubMed ID: 19194119
    [Abstract] [Full Text] [Related]

  • 37. Controlling emesis: what is it worth?
    Fox SC.
    J Clin Oncol; 2006 Dec 10; 24(35):5617; author reply 5616-7. PubMed ID: 17158553
    [No Abstract] [Full Text] [Related]

  • 38. Mucositis in malignant hematology.
    Niscola P.
    Expert Rev Hematol; 2010 Feb 10; 3(1):57-65. PubMed ID: 21082934
    [Abstract] [Full Text] [Related]

  • 39. The gastrointestinal complications of oncologic therapy.
    Shafi MA, Bresalier RS.
    Gastroenterol Clin North Am; 2010 Sep 10; 39(3):629-47. PubMed ID: 20951921
    [Abstract] [Full Text] [Related]

  • 40. Gastrointestinal complications of oncologic therapy.
    Davila M, Bresalier RS.
    Nat Clin Pract Gastroenterol Hepatol; 2008 Dec 10; 5(12):682-96. PubMed ID: 18941434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.